SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-011355
Filing Date
2023-03-31
Accepted
2023-03-31 16:01:57
Documents
58
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fbrx-20221231.htm   iXBRL 10-K 2355387
2 EX-10.16 fbrx-ex10_16.htm EX-10 189799
3 EX-21.1 fbrx-ex21_1.htm EX-21 9715
4 EX-23.1 fbrx-ex23_1.htm EX-23 6192
5 EX-31.1 fbrx-ex31_1.htm EX-31 20348
6 EX-31.2 fbrx-ex31_2.htm EX-31 20512
7 EX-32.1 fbrx-ex32_1.htm EX-32 11886
8 EX-32.2 fbrx-ex32_2.htm EX-32 11711
  Complete submission text file 0000950170-23-011355.txt   7692769

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fbrx-20221231_cal.xml EX-101.CAL 41069
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fbrx-20221231_lab.xml EX-101.LAB 428791
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fbrx-20221231.xsd EX-101.SCH 44851
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fbrx-20221231_def.xml EX-101.DEF 157248
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fbrx-20221231_pre.xml EX-101.PRE 290973
52 EXTRACTED XBRL INSTANCE DOCUMENT fbrx-20221231_htm.xml XML 1191379
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38052 | Film No.: 23787399
SIC: 2834 Pharmaceutical Preparations